BioCentury
ARTICLE | Company News

Manchester Pharmaceuticals, Retrophin deal

February 17, 2014 8:00 AM UTC

Manchester Pharmaceuticals LLC, Fort Collins, Colo. Retrophin Inc. (NASDAQ:RTRX), New York, N.Y. Business: Cardiovascular, Gastrointestinal, Endocrine/Metabolic Retrophin will acquire fellow rare dis...